CORRECTION article

Front. Immunol.

Sec. Vaccines and Molecular Therapeutics

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1639717

Correction: Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer

Provisionally accepted
Yanan TongYanan Tong1Guoxiu LuGuoxiu Lu2Zhiguo WangZhiguo Wang1Shanhu HaoShanhu Hao1Zhang GuoxuZhang Guoxu1*Hongwu SunHongwu Sun3*
  • 1General Hospital of Northern Theatre Command, Shenyang, China
  • 2School of Medicine and Bioinformatics Engineering, Northeastern University, Shenyang, China
  • 3College of Pharmacy, Third Military Medical University, Chongqing, China, Chongqing, China

This article is a correction to:

  1. Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Incorrect affiliationIn the published article, there was an error in affiliation(s) [Guoxiu Lu，These authors have contributed equally to this work and share first authorship with Yan nan Tong .And the affiliation of Guoxiu Lu are 1 and 2.: 1 Department of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, China, 2College of Medicine and Biological Information Engineering, Northeastern University, Shenyang. ]. Instead of “[ 1 Department of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, China, 2College of Medicine and Biological Information Engineering, Northeastern University, Shenyang. ]”, it should be “2 Medicine and Biological Information Engineering, Northeastern University.Shenyang. Liaoning，China”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: colorectal cancer, F. nucleatum, Tubeimuside I, Dendritic Cells, Vaccine

Received: 02 Jun 2025; Accepted: 03 Jun 2025.

Copyright: © 2025 Tong, Lu, Wang, Hao, Guoxu and Sun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Zhang Guoxu, General Hospital of Northern Theatre Command, Shenyang, China
Hongwu Sun, College of Pharmacy, Third Military Medical University, Chongqing, China, Chongqing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material